Physician profile
Tammy E Novak
NPI 1376658682
$844.12
in general payments reported to CMS, 2019-2025
19 companies · $36.84 in 2025
The $36.84 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.76 · 2020: $105 · 2021: $339 · 2022: $91.29 · 2023: $197 · 2024: $19.71 · 2025: $36.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $105.87 | 2020-2021 | |
| Hologic Sales and Service, LLC | $93.89 | 2023-2025 | Aptima, Myosure Tissue Removal Device, Thinprep 2000 Processor |
| Organon LLC | $83.37 | 2021-2025 | Nexplanon, Nuvaring |
| Avanos Medical | $72.39 | 2023 | On-Q* Pump and Accessories |
| Agile Therapeutics, INC. | $69.38 | 2021 | |
| Aspira Women'S Health INC | $66.74 | 2021-2022 | |
| Exeltis, USA INC. | $63.83 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $57.53 | 2022 | |
| Coopersurgical, INC. | $48.77 | 2019-2024 | Paragard T 380a |
| Mylan Pharmaceuticals INC. | $27.53 | 2021 | |
| Evofem Biosciences, INC. | $25.75 | 2021 | |
| Amgen INC. | $20.67 | 2020 | |
| Mayne Pharma Commercial LLC | $20.34 | 2021 | |
| Therapeuticsmd, INC. | $18.36 | 2021 | |
| Astellas Pharma US INC | $17.89 | 2023 | Veozah |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $15.25 | 2019 | |
| Dysis Medical, INC. | $13.31 | 2021 | |
| Avion Pharmaceuticals | $11.80 | 2021 | |
| Medtronic Vascular, INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tammy Novak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.